BIODIVIDE LIMITED

SN15 3HR (South West)

Start Date End Date Funded Value Relevance

CSV

25 50 100

£99,991

May 15 - Jan 17

Preclinical Proof of Concept for LIF Nanotherapeutics for the Treatment of Multiple Sclerosis

Innovate UK award to LIF NANO RX LTD and Erik Miljan

£104,396

Mar 16 - Aug 17

VESCO-R®: Peripheral Blood Derived Mesenchymal Stem Cell Therapy in Regenerative Medicine

Innovate UK award to BIODIVIDE LIMITED

£5,000

Aug 15 - Jan 16

Minimal Invasive Stem Cell Isolation Technology for Veterinary Medicine

Innovate UK award to BIODIVIDE LIMITED

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}